Scarica l'app Stockscreener
5.205
4.32%
-0.235
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Precedente Chiudi:
$5.44
Aprire:
$5.2
Volume 24 ore:
15.44M
Relative Volume:
0.41
Capitalizzazione di mercato:
$2.23B
Reddito:
$64.60M
Utile/perdita netta:
$-377.75M
Rapporto P/E:
-3.3581
EPS:
-1.55
Flusso di cassa netto:
$-335.64M
1 W Prestazione:
-11.93%
1M Prestazione:
-5.19%
6M Prestazione:
-8.68%
1 anno Prestazione:
-21.61%
Intervallo 1D:
$5.115
$5.32
Intervallo di 1 settimana:
$5.115
$6.10
Portata 52W:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Nome
Recursion Pharmaceuticals Inc
Settore
Industria
Telefono
(385) 269-0203
Indirizzo
41S RIO GRANDE STREET, SALT LAKE CITY
Confronta RXRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
5.21 | 2.37B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.90 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.68 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.56 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Iniziato | Needham | Buy |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-04 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Iniziato | Berenberg | Buy |
| 2021-05-11 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Goldman | Neutral |
| 2021-05-11 | Iniziato | JP Morgan | Neutral |
| 2021-05-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Recursion Pharmaceuticals to engage investors at key conferences - Traders Union
3 Things Investors Need to Know About Recursion Pharmaceuticals - The Motley Fool
Recursion (Nasdaq: RXRX) at Guggenheim, Jefferies conferences Nov. 11 and Nov. 18 - Stock Titan
Using Bollinger Bands to evaluate Recursion Pharmaceuticals Inc.Trade Exit Summary & Safe Entry Zone Identification - newser.com
How Recursion Pharmaceuticals Inc. stock reacts to bond yieldsEarnings Beat & Intraday High Probability Alerts - newser.com
AI in pharmaceuticals Market Is Booming Worldwide | Major Giants - openPR.com
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards? - Nasdaq
How to interpret RSI for Recursion Pharmaceuticals Inc. stockTreasury Yields & Proven Capital Preservation Tips - newser.com
Will earnings trigger a reversal in Recursion Pharmaceuticals Inc.July 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Is Recursion Pharmaceuticals Inc. stock poised for growthWeekly Trade Recap & Reliable Breakout Stock Forecasts - newser.com
How Recursion Pharmaceuticals Inc. stock valuations compare to rivals2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Will Recursion Pharmaceuticals Inc. stock maintain growth storyQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
When is the best time to exit Recursion Pharmaceuticals Inc.Quarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
Biotech Stocks To Add to Your WatchlistOctober 30th - MarketBeat
Is it time to cut losses on Recursion Pharmaceuticals Inc.July 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Top Biotech Stocks To Follow TodayNovember 1st - MarketBeat
Can Recursion Pharmaceuticals Inc. stock hit record highs againStock Surge & Real-Time Market Sentiment Alerts - newser.com
Recursion Pharmaceuticals (RXRX) Stock: CEO Sells $5.8 Million in Shares Following Exscientia Merger - CoinCentral
Top Biotech Stocks To Keep An Eye OnOctober 28th - MarketBeat
Best Biotech Stocks To Follow TodayOctober 31st - MarketBeat
Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Merger and Partnerships - Quiver Quantitative
Promising Biotech Stocks To Follow TodayOctober 14th - MarketBeat
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? - The Globe and Mail
Has Recursion Pharmaceuticals Inc. formed a bullish divergenceVolume Spike & Real-Time Price Movement Reports - newser.com
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech
Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline - sharewise.com
Recursion Pharmaceuticals Incannounces Roche's exercise of option for Microglia MapSEC filing - MarketScreener
Roche Exercises Option with Recursion Pharmaceuticals - TipRanks
Recursion Pharmaceuticals Announces Roche's Option Exercise - TradingView
Published on: 2025-10-29 07:02:21 - newser.com
Recursion Pharmaceuticals (RXRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Is Hindustan Media Ventures Limited Stock Poised for a Breakout in YEARVolume Weighted Average Price & Master Stock Selection - earlytimes.in
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors - sharewise.com
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Recursion Pharmaceuticals (RXRX): Exploring Valuation as AI Expansion, Key Merger, and Clinical Progress Boost Interest - simplywall.st
Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.73%
0.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):